Editorial: Recent advancement of the cardio-renal protective effects of SGLT2 inhibitors in people with and without diabetes

• Satoru Kuriyama,
• Masaaki Nakayama

Affiliations

Satoru Kuriyama

Jikei University School of Medicine, Tokyo, Japan

Masaaki Nakayama

Division of Nephrology, St. Luke's International University, Tokyo, Japan